Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Crescent Pharma International Limited, 260 Trip San Albert, Gzira GZR 1150, Malta
Dilacort 2.5 mg gastro-resistant tablets.
Pharmaceutical Form |
---|
Gastro-resistant tablet. [Tablet] Dark brown, circular, deep biconvex, enteric coated tablets. |
Each tablet contains 2.5 mg prednisolone.
Excipients with known effect: This medicine contains lactose.
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Prednisolone |
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |
List of Excipients |
---|
Core Components: Lactose monohydrate Coating Components: Hypromellose |
PVC/PVdC/Aluminium blisters.
Pack size of 28 tablets.
Crescent Pharma International Limited, 260 Trip San Albert, Gzira GZR 1150, Malta
PA22699/001/001
Date of first authorisation: 04th January 2013
Date of last renewal: 30th November 2017
Drug | Countries | |
---|---|---|
DILACORT | Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.